Skip to content

A Pilot Study to Examine Efficacy of Peer Mentoring in Promoting Medication Adherence Among People Living With HIV/AIDS

A Pilot Study Using Randomized, Parallel Design to Compare the Efficacy of Peer Mentoring Versus Standard of Care in Promoting Medication Adherence Among Newly Diagnosed and Medication Non-adherent People Living With HIV/AIDS

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02025322
Enrollment
36
Registered
2014-01-01
Start date
2013-09-30
Completion date
2015-09-30
Last updated
2015-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

HIV/AIDS, Peer Mentoring, Medication Adherence, Medication Non-adherent, Newly diagnosed, HIV-positive individuals, HIV viral load, CD4 lymphocyte cell counts, Treatment adherence, Health literacy, Self-efficacy

Brief summary

This study aims to investigate the effectiveness of an in-person peer mentoring and health literacy intervention on improving medication adherence, HIV-1 viral load, CD4+ T lymphocyte counts, and HIV medical appointment attendance among newly-diagnosed and/or medication non-adherent HIV-positive individuals, compared to standard of care provider/staff-delivered education.

Interventions

BEHAVIORALPeer Mentoring

Participants in the Peer Mentoring arm will be paired with a Peer Mentor for the duration of the 4-month intervention. Peer Mentors are HIV-positive patients who demonstrate high levels of medication and treatment adherence and are knowledgeable about HIV/AIDS and barriers to care. During the 4-month intervention, Peer Mentors will contact participants weekly via in-person, phone, or email, with the option to provide more frequent contact, if needed. Peer Mentors will provide social support and remind participants to take their medications and attend upcoming medical appointments. Study participants will also attend four monthly, one hour workshops on HIV/AIDS, medication adherence, health literacy, and health and wellness, which will be developed and co-facilitated by Peer Mentors.

Sponsors

Merck Sharp & Dohme LLC
CollaboratorINDUSTRY
Jury Candelario
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All of the following criteria must be met for a participant to be eligible for the study: * Confirmed diagnosis of HIV-1 * Newly diagnosed and initiating treatment (e.g., treatment naive) OR off medications for more than fourteen consecutive days (2 weeks) and re-initiating treatment OR currently on antiretroviral therapy with demonstrated ongoing adherence problems (missing more than 3 doses per month) * Has a detectable (greater than 50 copies/ml) HIV-1 viral load * Is able to obtain HIV medications during the entire study period (e.g., if uninsured, is enrolled in AIDS Drug Assistance Program).

Exclusion criteria

Subject is ineligible for this study if: * He/She suffers from cognitive impairment, active psychosis, or has a known history of harming others, OR * He/She has a severe mental health and/or substance abuse condition that requires residential or inpatient treatment, OR * The medical provider believes participation would not be in the best interest of the subject for other reasons.

Design outcomes

Primary

MeasureTime frameDescription
Efficacy of Peer Mentoring on Improving Medication Adherence4 months post-baselineTest the efficacy of a peer mentoring intervention on improving medication adherence among newly diagnosed and/or medication non-adherent HIV-positive individuals, compared to standard of care.

Secondary

MeasureTime frameDescription
Assess the Long-Term Impact of Peer Mentoring on Medication adherence6-months post-baselineAssess the long-term impact of peer mentoring on medication adherence among newly diagnosed and/or medication non-adherent HIV-positive individuals, compared to standard of care.

Other

MeasureTime frameDescription
Examine the Impact of Peer Mentoring on HIV viral load and CD4 lymphocyte cell counts6-months post-baselineCompared to standard of care, participants receiving peer mentoring will have significantly lower HIV viral loads and significantly higher CD4 lymphocyte cell counts between baseline and six months post-baseline.
Examine the Impact of Peer Mentoring on HIV Medical Appointment Attendance6-months post-baselineExamine the impact of peer mentoring on HIV medical appointment attendance among newly diagnosed and/or medication non-adherent HIV-positive individuals, compared to standard of care.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026